• 17TH SEPTEMBER 2024

    September 2024 Price Concessions 1st Update

    Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (17/09/2024) announced the following list of price concessions for September 2024: Drug  Pack size Price concession Benzydamine 0.15% mouthwash sugar free 300 £4.51 Clomipramine 50mg capsules 28 £7.99 Clotrimazole

    Read more
    • 13TH SEPTEMBER 2024

    Expiry of nine Quetiapine SSPs (SSP062-SSP070)

    The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Quetiapine tablets is now available to meet normal demand. As a result the following  Serious Shortage Protocols, will expire at 23.59pm on Friday 13 September 2024. After this date, any prescriptions for Quetiapine tablets must be dispensed in accordance with the prescription,

    Read more
    • 12TH SEPTEMBER 2024

    MPs back pharmacies at Parliamentary drop-in event

    Community Pharmacy England met with 45 MPs and parliamentary staff at the Houses of Parliament earlier this week (Tuesday 10th September 2024) to discuss the critical pressures on community pharmacies and their important role in local healthcare. During the busy event, MPs were shown how residents in their constituencies benefit from pharmacy services including Pharmacy

    Read more
    • 12TH SEPTEMBER 2024

    ‘Huge potential’ for community pharmacy recognised in NHS review

    Both the huge potential for expanding the clinical role of pharmacists and a growing concern for community pharmacy’s resources have been recognised in an independent investigation into the NHS. The final report of Lord Darzi’s review of the NHS in England, commissioned by the Secretary of State for Health and Social Care, has concluded that

    Read more
    • 12TH SEPTEMBER 2024

    MHRA Class 3 Medicines Recall: Evorel Sequi (Theramex HQ UK Ltd)

    MHRA Class 3 Medicines Recall: Evorel Sequi (Theramex HQ UK Ltd) Drug alert number: EL (24)A/41 Date issued: 12 September 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines defect information notice for: Evorel Sequi (Theramex HQ UK Ltd) Company name:Theramex HQ UK Ltd Product name: Evorel Sequi, PL 49105/0010

    Read more